What is the essential initial step in malignant hyperthermia management?

What is the essential initial step in malignant hyperthermia management?

• A. Stop triggering agents, administer 100% O2, and give dantrolene promptly.
• B. Increase inhaled anesthetic concentration to suppress symptoms.
• C. Administer epinephrine alone.
• D. Delay treatment to confirm diagnosis.

Answer: (A)

In malignant hyperthermia management, the first action is to stop all triggering agents, provide 100% oxygen, and give dantrolene promptly. Stopping the triggering agents halts the ongoing abnormal calcium release in skeletal muscle that drives the hypermetabolic crisis. Giving 100% oxygen ensures tissues receive adequate oxygen as the body’s demand surges and helps manage rising CO2 and acidosis that accompany the crisis. Dantrolene directly counteracts the heart of the problem by inhibiting the ryanodine receptor, preventing further calcium release, reducing muscle rigidity, decreasing heat production, and blunting the metabolic storm. This trio—stopping triggers, high-flow oxygen, and rapid dantrolene administration—is essential because malignant hyperthermia can progress quickly to life-threatening complications if treatment is delayed. By contrast, increasing anesthetic concentration would worsen the condition, epinephrine alone doesn’t address the underlying calcium dysregulation, and delaying therapy until diagnosis is confirmed risks rapid deterioration.

In malignant hyperthermia management, the first action is to stop all triggering agents, provide 100% oxygen, and give dantrolene promptly. Stopping the triggering agents halts the ongoing abnormal calcium release in skeletal muscle that drives the hypermetabolic crisis. Giving 100% oxygen ensures tissues receive adequate oxygen as the body’s demand surges and helps manage rising CO2 and acidosis that accompany the crisis. Dantrolene directly counteracts the heart of the problem by inhibiting the ryanodine receptor, preventing further calcium release, reducing muscle rigidity, decreasing heat production, and blunting the metabolic storm. This trio—stopping triggers, high-flow oxygen, and rapid dantrolene administration—is essential because malignant hyperthermia can progress quickly to life-threatening complications if treatment is delayed. By contrast, increasing anesthetic concentration would worsen the condition, epinephrine alone doesn’t address the underlying calcium dysregulation, and delaying therapy until diagnosis is confirmed risks rapid deterioration.